Institutional members access full text with Ovid®

Baseline renal insufficiency and risk of death among HIV-infected adults on antiretroviral therapy in Lusaka, Zambia

Mulenga, Lloyd Ba; Kruse, Ginaa; Lakhi, Shabirb; Cantrell, Ronald Aa,c; Reid, Stewart Ea,c; Zulu, Isaacd,e; Stringer, Elizabeth Ma,c; Krishnasami, Zipporahc; Mwinga, Alwynd; Saag, Michael Sc; Stringer, Jeffrey SAa,c; Chi, Benjamin Ha,c

doi: 10.1097/QAD.0b013e328307a051
Epidemiology and Social

Objective: To examine the association between baseline renal insufficiency and mortality among adults initiating antiretroviral therapy (ART) in an urban African setting.

Design: Open cohort evaluation.

Methods: We examined mortality according to baseline renal function among adults initiating ART in Lusaka, Zambia. Renal function was assessed by the Cockcroft–Gault method, the Modification of Diet in Renal Disease equation, and serum creatinine.

Results: From April 2004 to September 2007, 25 779 individuals started ART with an available creatinine measurement at baseline. When creatinine clearance was calculated by the Cockcroft–Gault method, 8456 (33.5%) had renal insufficiency: 73.5% were mild (60–89 ml/min), 23.4% moderate (30–59 ml/min), and 3.1% severe (<30 ml/min). Risk for mortality at or before 90 days was elevated for those with mildly [adjusted hazard ratio (AHR) = 1.7; 95% confidence interval (95% CI) = 1.5–1.9], moderately (AHR = 2.3; 95% CI = 2.0–2.7), and severely (AHR = 4.3; 95% CI = 3.1–5.5) reduced creatinine clearance. Mild (AHR = 1.4; 95% CI = 1.2–1.6), moderate (AHR = 1.9; 95% CI = 1.5–2.3), and severe (AHR = 3.6; 95% CI = 2.4–5.5) insufficiency were also associated with increased mortality after 90 days, when compared with those with normal renal function. Trends were similar when renal function was estimated with Modification of Diet in Renal Disease or serum creatinine.

Conclusion: Renal insufficiency at time of ART initiation was prevalent and associated with increased mortality risk among adults in this population. These results have particular relevance for settings like Zambia, where tenofovir – a drug with known nephrotoxicity – has been adopted as part of first-line therapy. This emphasizes the need for resource-appropriate screening algorithms for renal disease, both as part of ART eligibility and pretreatment assessment.

aCentre for Infectious Disease Research in Zambia

bUniversity Teaching Hospital, Lusaka, Zambia

cSchools of Medicine and Public Health, University of Alabama, Birmingham, Alabama, USA

dUS Centers for Disease Control and Prevention Global AIDS Program

eSchool of Medicine, University of Zambia, Lusaka, Zambia.

Received 13 March, 2008

Revised 25 April, 2008

Accepted 1 May, 2008

Correspondence to Dr Ben Chi, Plot 1275 Lubutu Road, P.O. Box 34681, Lusaka, Zambia. E-mail:

© 2008 Lippincott Williams & Wilkins, Inc.